STOCK TITAN

BioMarin to Participate in Four Upcoming Virtual Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

BioMarin Pharmaceutical (NASDAQ: BMRN) will participate in four upcoming virtual investor conferences, as announced on September 15, 2020. Management will deliver presentations, available via audio webcast, on the company's innovative therapies for serious rare disorders. Interested parties can access the live webcast and an archived version through the company’s investor relations website. BioMarin's portfolio includes six commercialized products, with several candidates in clinical and pre-clinical stages. For more details, visit www.biomarin.com.

Positive
  • None.
Negative
  • None.

SAN RAFAEL, Calif., Sept. 15, 2020 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will participate in four upcoming virtual conferences.  An audio webcast of the presentations will be available live. You can access the webcast at: https://investors.biomarin.com/. An archived version of the remarks will also be available through the Company's website for a limited time following the conference.

About BioMarin

BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates. 

For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.

Contacts:  


Investors                                                  

Media

Traci McCarty                                             

Debra Charlesworth

BioMarin Pharmaceutical Inc.                         

BioMarin Pharmaceutical Inc.

(415) 455-7558                                                

(415) 455-7451

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/biomarin-to-participate-in-four-upcoming-virtual-investor-conferences-301128234.html

SOURCE BioMarin Pharmaceutical Inc.

FAQ

When will BioMarin participate in the upcoming virtual investor conferences?

BioMarin will participate in four virtual investor conferences, with details provided in their announcement on September 15, 2020.

How can I access the webcasts of BioMarin's investor presentations?

You can access the live webcasts of BioMarin's presentations through their investor relations website at https://investors.biomarin.com.

What types of products does BioMarin develop?

BioMarin develops therapies for serious and life-threatening rare disorders, with six commercialized products and multiple clinical candidates.

Where can I find more information about BioMarin Pharmaceutical?

For additional information, visit BioMarin's official website at www.biomarin.com.

What is the stock symbol for BioMarin?

The stock symbol for BioMarin Pharmaceutical is BMRN.

BioMarin Pharmaceuticals Inc

NASDAQ:BMRN

BMRN Rankings

BMRN Latest News

BMRN Stock Data

12.46B
188.90M
0.87%
97.78%
2.68%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
NOVATO